NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said second-quarter revenues increased 236 percent as R&D spending rose 44 percent and profit increased over 240 percent.
 
Total receipts for the three months ended June 30 increased to $2.4 billion from $714 million year over year. Last year's results reflect Thermo Electron's operations prior to its merger with Fisher Scientific in November. Including both firm's results from last year, second-quarter revenues increased 9 percent year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.